Drug-labels.com

Oxsoralen Cap 10mg Product Monograph

Status:
Prescription (Rx) Current status: Cancelled Post Market Facts
Strength:
10 mg
Active ingredient:

Product Monograph - Oxsoralen Cap 10mg

PHARMACEUTICAL INFORMATION

Drug Substance: Methoxsalen, USP

Chemical Name: (1) 7H-Furo[3,2-g][1]benzopyran-7-one,

9-methoxy-;

(2) 9-Methoxy-7H-furo[3,2-g][1]benzo- pyran-7-one

Structural Formula:

Molecular Formula: C12H804

Molecular Weight: 216.19

Description: methoxsalen occurs as white to cream- colored, fluffy, odourless needles insoluble in water, soluble in acetone

and chloroform

Stability: Oxsoralen capsules should be stored in well-closed, light-resistant containers at controlled room temperature (15-30o C)

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 01946374

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Oxsoralen Cap 10mg

Rx or OTC
Prescription (Rx)?
DIN 01946374
Schedule(s) PRESCRIPTION
Active ingredient(s) Methoxsalen 10 MG
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. D Dermatologicals
    1. D05 Antipsoriatics
      1. D05B Antipsoriatics for systemic use
        1. D05BA Psoralens for systemic use
          1. D05BA02 Methoxalen, systemic
Company VALEANT CANADA LP / VALEANT CANADA S.E.C.
Current status Cancelled Post Market
Current status date August 5, 2015

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.